CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 75 enrolled
Drug / intervention
Desflurane +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01219881
NCT01219881Phase 3Completed
CompareCT.gov

A Randomized, Double-Blind, Double-Arm Trial Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery Under General Anesthesia With a Laryngeal Mask Airway (LMA)

Ohio State University·interventional·Posted Oct 13, 2010·Updated Nov 16, 2021

In Brief

A Phase 3 clinical trial evaluating Desflurane and Sevoflurane for Cystoscopes and 2 related conditions. Completed, enrolled 75 participants across 1 site.

Detailed Summary

This is a single-center, prospective, randomized, double-blind, double-arm trial including 68 subjects scheduled to undergo urological cystoscope surgeries under general anesthesia (GA) with intubation through a laryngeal mask airway (LMA) at The Ohio State University Medical Center (OSUMC). Double blinding will be based on both the subject and the research staff being unaware of which trial arm the subject is randomized into. Eligible subjects that provide voluntary and written informed consent will be included in this study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystoscopes, Baxter Anaesthesia Brand of Desflurane, Sevoflurane
CountriesUnited States
CollaboratorsBaxter Healthcare Corporation

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 13, 2010
Enrollment StartSep 1, 2010
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 15.7 years ago

Interventions

Desfluranedrug

5.4 to 7.4% desflurane

Sevofluranedrug

1.4 to 2.5% Sevoflurane